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Edited by Dr. Maurice MontalAbstract In this study, we isolated and pharmacologically char-
acterized the ﬁrst a-like toxin from the venom of the scarcely stud-
ied Iranian scorpionOdonthobuthus doriae. The toxin was termed
OD1 and its primary sequence was determined: GVRDA-
YIADDKNCVYTCASNGYCNTECTKNGAESGYCQWIGR-
YGNACWCIKLPDEVPIRIPGKCR. Using the two-electrode
voltage clamp technique, the pharmacological eﬀects of OD1were
studied on three cloned voltage-gated Na+ channels expressed in
Xenopus laevis oocytes (Nav1.2/b1, Nav1.5/b1, para/tipE). The
inactivation process of the insect channel, para/tipE, was severely
hampered by 200 nMofOD1 (EC50 = 80 ± 14 nM) while Nav1.2/
b1 still was not aﬀected at concentrations up to 5 lM. Nav1.5/b1
was inﬂuenced at micromolar concentrations.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Voltage-gated Na+ channels (VGSCs) are membrane span-
ning proteins responsible for action potentials in neurons
and most excitable cells [1]. Until this date nine mammalian
(Nav1.1–Nav1.9) and three insect VGSCs have been cloned
[2,3]. Since VGSCs play an important physiological role in ver-
tebrates and invertebrates, they are targeted by toxins from
animal venoms and plants [4].
Most scorpion neurotoxins targeting VGSCs are single chain
polypeptides composed of 60–70 amino acids cross-linked by
4-disulﬁde bridges [5–7]. These polypeptides comprise twoAbbreviations: DTT, dithiothreitol; MS, mass spectrometry; RP-
HPLC, reversed-phase high performance liquid chromatography;
TEVC, two-electrode voltage clamp; TFA, triﬂuoro acetic acid;
VGSC(s), voltage-gated Na+ channel(s)
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doi:10.1016/j.febslet.2005.06.052main groups: a- and b-toxins [8–10]. Scorpion a-toxins bind
to site 3 and prolong the action potential by slowing the inac-
tivation of VGSCs. According to their diﬀerent pharmacolog-
ical and binding properties, the a-toxins can be further divided
into three subgroups, classical a-, a-like and insect a-toxins.
Classical a-toxins (e.g., AaHII, LqhII) are highly toxic to
mammals, whereas the insect a-toxins (e.g., LqhaIT) are highly
toxic to insects. The more recently characterized a-like toxins
(e.g., BmK M1, LqhIII) act on both mammals and insects,
but are unique in their inability to bind to rat synaptosomes
despite a high toxicity by intravenous injection [8,11–14].
The Iranian yellow scorpion Odonthobuthus doriae is a mem-
ber of the Buthidae family. The genus Buthus, with the two
species doriae and odonturus, are endemic to the Old World,
mainly the Middle East [7,15]. Speciﬁcally, the scorpion de-
scribed here can be found in the central and southern part of
Iran. Its sting can cause various eﬀects ranging from local pain,
inﬂammation and necrosis to muscle paralysis and hematuria.
Since very little is published about this scorpion and the bioac-
tive substances in its venom, we tried to determine whether
VGSC toxins were present.
As a consequence, we report here the isolation and pharma-
cological characterization of OD1, the ﬁrst a-like toxin from
the venom of the Iranian yellow scorpion O. doriae scorpion.2. Materials and methods
2.1. Puriﬁcation
500 mg of the crude venom (gift from Dr. Akbary; Vaccine and Ser-
um production and Research Institute of Razi, Karaj, Iran) was dis-
solved in 10 ml of mobile phase (100 mM ammonium acetate in
water, pH 6.8) (Merck, Germany). After sample clariﬁcation by centri-
fugation, fractionation was carried out using two 210 · 3.5 cm Sepha-
dex G50 columns in series (ﬂow rate: 1 ml/min) (Pharmacia, Sweden)
at room temperature (20–22 C) [16,17]. Absorbance was measured at
280 nm. Toxicity guided separation of various protein fractions was
accomplished after i.v. injection into mice (white, male, 18–20 g). Frac-
tion 4, containing the toxin, was further puriﬁed by ion exchange chro-
matography (Pharmacia) using a 2.5 · 15 cm column (elution buﬀers:
Tris 50 mM at pH 8 (solution A) and Tris 50 mM at pH 8 plus 1 M
NaCl (Solution B)). The ﬁrst equilibrium step of 60 ml of solution A
was followed by a gradient from solution A to solution B (240 ml).
The ﬂow rate was 2 ml/min and the absorbance was measured at
280 nm.blished by Elsevier B.V. All rights reserved.
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ther puriﬁed on a semi-preparative reversed-phase high performance li-
quid chromatography (RP-HPLC) Vydac C8 column (250 · 10 mm,
5 lm) (Hesperia, CA, USA) equilibrated with 0.1% w/v triﬂuoro acetic
acid (TFA). Elution was performed using a linear gradient (20–30%) of
acetonitrile containing 0.1% w/v TFA in 45 min (ﬂow rate 3 ml/min).
Absorbance was recorded at 215 nm. The ﬁnal purity of the toxin
was assessed on an analytical Supelco RP-HPLC column
(250 · 4.6 mm, 5 lm) using solution A (0.1% TFA in water) and solu-Fig. 1. Puriﬁcation of OD1 from the venom of O. doriae. (A) Crude venom
Toxic fraction 4 was recovered and dried. (B) Ion exchange chromatography
(pH 8) plus 1 M NaCl. (C) Fraction 3 (2 mg) of the ion exchange step was fu
recovered and dried (800 lg). (D) The purity of the toxin was assessed on an
total venom.tion B (0.1% TFA in acetonitrile) with a gradient up till 60% B over a
period of 45 min (SMART, Pharmacia). Flow rate and absorbance
were 500 ll/min and 214 nm, respectively.2.2. Mass spectrometry
The molecular mass of OD1 and fragments generated by enzymatic
cleavage were determined by MALDI-TOF mass spectrometry (MS)
on a Reﬂex IV (Bruker Daltonics GmbH, Germany) using a recrystal-(500 mg) was dialyzed and 107 mg was fractionated by gel ﬁltration.
of fraction 4 (9 mg) obtained in (A). Solution B consists of Tris 50 mM
rther puriﬁed using a C8 column. Fractions eluting at 26.9 min (*) were
analytical RP-HPLC C18 column. OD1 encompasses about 1% of the
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formed using standard peptide and protein mixtures (Bruker Daltonic
GmbH).
2.3. Sequence determination
The ﬁrst 47 residues of the primary structure of the OD1 were deter-
mined by automated Edman degradation (Procise, Applied Biosystem,
USA) (Fig. 2). Nanoﬂow electrospray ionization hybrid quadrupole
time of ﬂight MS was performed on a Q-TOF system (Micromass,
UK). For OD1, 1 ll of a 41.1 lM OD1 solution and for enzymatic
fragments, 1 ll of the collected fraction was used.
In enzymatic cleavage, 50 ll of a 41.1 lM OD1 solution was treated
with 1 lg of modiﬁed porcine trypsin (Promega) in 0.2 M NH4CO3
(pH 8) for 18 h at 37 C and subsequently with 50 mM dithiothreitol
(DTT) for 2 h at 37 C. Tryptic fragments were separated on a Waters
Symmetry C18 (4.6 · 250 mm, 5 lM) column using a gradient from 1%
to 50% acetonitrile with 0.1% TFA in 40 min (ﬂow rate: 1 ml/min).
Peaks were collected manually.
Next, 50 ll of a 41.1 lM OD1-solution was treated with 50 mM
DTT for 2 h at 37 C and with 0.2 lg endoproteinase Asp-N (Roche)
in 10 mM Tris (pH 8) for 24 h at 37 C. Resulting fragments were sep-
arated on a Waters Symmetry C18 column using a gradient from 1% to
50% acetonitrile with 0.1% TFA in 30 min (ﬂow rate: 1 ml/min). Peaks
were collected manually.
2.4. Electrophysiological recordings
For the expression in Xenopus laevis oocytes, the Nav1.5 and b1
genes were subcloned into pSP64T [18]. For in vitro transcription,
Nav1.5/pSP64T was ﬁrst linearized with XbaI and b1/pSP64T withFig. 2. (A) (1) Result from direct Edman degradation of the entire toxin. (2) a
(conﬁrmatory). Edman degradation was used for distinguishing between le
MALDI-TOF MS and Q-TOF MS (conﬁrmatory). Edman degradation was u
(B) Comparison of the amino-acid sequence of OD1 with other similar toxin
helix). (*) Residues conserved in all listed toxins. The C-terminus of OD1 isEcoRI. Next, capped cRNAs were synthesized using the large-scale
SP6 mMESSAGE–mMACHINE transcription kit (Ambion, USA).
The para/pGH19-13-5 vector, tipE/pGH19 vector and Nav1.2/pLCT1
vector were linearized with NotI and transcribed with the T7 mMES-
SAGE–mMACHINE kit (Ambion) [19–21].
The harvesting of oocytes from anaesthetized female X. laevis frogs
was as previously described [22]. The ND96 solution was used for incu-
bating the oocytes and contained (in mM): 96 NaCl, 2 KCl, 1.8 CaCl2,
1 MgCl2, 5 HEPES, pH 7.4, supplemented with 50 mg/l gentamicin sul-
fate and 180 mg/l theophyllin. Two-electrode voltage clamp (TEVC)
recording on oocytes was as previously described [8,11–14]. Whole cell
currents were recorded 2–4 days after injection. Currents were ﬁltered
at 1 kHz and sampled at 5 kHz. Digital leak subtraction of the current
records was carried out using a P/2 protocol. The degree of fast inac-
tivation was assayed by measuring the I10ms/Ipeak ratio which gives an
estimate of the probability for the channels not to be inactivated after
10 ms [5]. Curve manipulations were performed using pClamp8 (Axon
instruments, USA) and Origin software (Microcal, USA).3. Results
3.1. Puriﬁcation and characterization
After puriﬁcation of the bio-active fraction using conven-
tional chromatography techniques (as shown in Fig. 1) se-
quence determination of the puriﬁed toxin yielded a peptide
of 65 residues, amidated at the C-terminus, termed OD1.nd (3) Trypsin cleavage followed by MALDI-TOFMS and Q-TOFMS
ucine/isoleucine and glutamine/lysine. (4) AspN cleavage followed by
sed for distinguishing between leucine/isoleucine and glutamine/lysine.
s. Secondary structures are indicated on top (B, b-sheet; T, turn; H, a-
amidated. Sequences taken from [6,7,29].
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7204.8 Da (theoretical mass: 7206.2 Da).
The sequence of OD1 was aligned with other similar se-
quences by using ClustalW (http://www.ebi.ac.uk/clustalw).
Scorpion a-toxins with high similarity include LqqIV (from
Leiurus quinquestriatus quinquestriatus, 92%), LqhIV (from
Leiurus quinquestriatus hebreaus, 91%), BjaIT (from Buthus
judaicus, 79%) and BmK M1/BmK M2 (from Buthus martensii
Karsch, 75%) (see Fig. 2) [6,14,23].Fig. 3. Eﬀect of OD1 on the inactivation kinetics of Nav1.2/b1, Nav1.5/b1 an
Nav1.2/b1, 5 lM; Nav1.5/b1, 2 lM; para/tipE, 200 nM. No eﬀect was observ
inactivation was observed for the other VGSCs. The voltage protocol with wh
curves reveal a large increase of Na+ ions inﬂux after addition of OD1 (n) in
reversal potential was seen. Note that the initial fast phase of activation was n
the increasing peak amplitude. Dose–response curve of OD1 on para/tipE (j
experiments. A Boltzmann sigmoidal ﬁt of the I10ms/Ipeak ratio data (see Sec3.2. Eﬀects of OD1 on VGSCs
Fig. 3 shows the maximum eﬃcacy of OD1 on Nav1.2/b1
(5 lM), Nav1.5/b1 (2 lM) and the insect VGSC para/tipE
(200 nM). Current traces were the result of a TEVC experi-
ment on VGSCs expressed together with their b1 subunit (tipE
for para). Current–voltage relationships were constructed by
using 50 ms step depolarizations to a voltage range between
70 and 40 mV from a holding potential of 90 mV. Current
traces recorded after the addition of OD1 reveal a slowing ofd para/tipE expressed in X. laevis oocytes. Concentrations shown are:
ed after addition of OD1 (2 lM) on Nav1.2/b1. An obvious slowing of
ich the I–V curves were obtained is shown at the lower left corner. I–V
comparison to control conditions (). No shift in activation voltage or
ot aﬀected by the toxin, the slowing of the late phase of inactivation and
) is shown at the bottom. Data are means ± S.E. mean of at least three
tion 2) provided the EC50 value of 80 ± 14 nM.
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veals that OD1 does not aﬀect Nav1.2/b1 at concentrations up
to 5 lM. On Nav1.5/b1, the slowing of inactivation only be-
came visible at concentrations above 1 lM. Para/tipE is by
far the most sensitive channel since OD1 completely inhibits
the inactivation process when 200 nM is added. A shift neither
in activation nor in reversal potential is seen on the studied
VGSCs. The slowing of inactivation induced by OD1 is con-
centration-dependent. The EC50 value of OD1 on Nav1.5/b1
was not determined since OD1 only had an eﬀect on this
VGSC at high concentrations (2 lM). The EC50 value of
OD1 on para/tipE was determined with a Boltzmann sigmoi-
dal ﬁt of the obtained data and was 80 ± 14 nM.4. Discussion
For the ﬁrst time, an a-like toxin from the venom of the Ira-
nian Yellow scorpion O. doriae, OD1, was puriﬁed and phar-
macologically characterized on three cloned VGSCs. OD1
does not inﬂuence the inactivation process of Nav1.2/b1. This
toxin does hamper the inactivation of Nav1.5/b1 but only at
high concentrations (2 lM). The main target is clearly the in-
sect VGSC, para/tipE, of which the inactivation process is
completely inhibited when 200 nM of OD1 is added
(EC50 = 80 ± 14 nM). The original sub-classiﬁcation of scor-
pion a-toxins relies on competition experiments and relative
toxicity tests [9]. Since we report here the eﬀects of OD1 on
three cloned VGSCs, the obtained data are compared to what
is known for other a-like toxins, electrophysiologically tested
on cloned VGSCs [24,25]. For instance, the activity of the a-
like toxin BmK M1 has been characterized on Nav1.2/b1,
Nav1.5/b1 and para/tipE and is similar to OD1 [14]. Further-
more, the pharmacological proﬁle of LqhIII, also regarded
as an a-like toxin [5,24,25], and OD1 (44% similarity) are alike.
Indeed, the fact that OD1 acts on VGSCs of both mammals
and insects is in concordance with the deﬁnition of a-like tox-
ins derived from binding studies. Therefore, based on its trade-
marks, OD1 can be regarded as a scorpion a-like toxin but
with a distinct preference for the insect VGSC.
Although the primary structure of OD1 possesses 92% sim-
ilarity with the a-toxin LqqIV [23] (targeting mammalian
VGSCs) (see Fig. 2), our bioassay reveals a distinct preference
for the insect VGSC, para. The region consisting of the reverse
turn (residues 8–12) in combination with C-tail (57–64), has re-
ceived much attention because of its involvement in the bind-
ing preference for phylogenetically distinct VGSCs [26,27]. A
recent study from Karbat et al. [28] reported the transfer of
these two motifs (termed NC-domain) of a scorpion insect a-
toxin (LqhaIT) to the scaﬀold of the anti-mammalian scorpion
a-toxin AaH2 resulting in activity on insects. Furthermore,
previous studies on BmK M1 revealed three functionally
important epitopes that underlie the molecular basis of mam-
mal and/or insect-selectivity: (1) the ﬁrst three N-terminal res-
idues; (2) the ﬁve-residue reverse turn (residues 8–12) in
combination with the C-tail (residues 57–64) and (3) the loop
between the b1 and b2 sheet (residues 40–43) [14]. Comparing
the sequence of OD1 to that of BmK M1, we see that the re-
gion consisting of the reverse turn is remarkably diﬀerent be-
tween these two toxins. While K8/P9/H10 in BmK M1 is
mostly basic, D8/D9/K10 in OD1 is more acidic. In addition,
a-like toxins possess a proline at position 9 while most a-toxinsdo not. Since a proline causes a nick in the secondary struc-
ture, the absence of this residue in OD1 can cause a diﬀerent
structure at this important region. Remarkably, LqqIV pos-
sesses the same sequence in this region as OD1. Even the C-tail
of these two toxins is identical. Furthermore, a recent study
from Arnon et al. [6] describes a novel toxin, BjaIT, as being
an insect-selective scorpion a-toxin which also shares high sim-
ilarity with LqqIV. However, based on LD50 values on mice
and competition studies on rat brain synaptosomes, LqqIV
has been classiﬁed as an a-toxin [23], in contrast to BjaIT
and OD1. Nonetheless, Ceste`le et al. [13] reported that LqqIV
does possess a low toxicity in insects and that this toxin is able
to bind to cockroach neuronal membranes [23]. Therefore,
LqqIV can in fact be considered an a-like toxin (like OD1)
but with a distinct preference for mammals (unlike OD1,
which has a distinct preference for insects).
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